Stephen Evans-Freke

Cibus Corp. engages in the development of plant and microbial platforms. Its focuses in inputting traits and agronomic traits in canola, rice, soybean, corn, and wheat crops. The company was founded by Peter Beetham, Greg Gocal, Keith Walker, and Rory Riggs in 2001 and is headquartered in San Diego, CA.

Part of Sanofi, Selectide Corp. is a pharmaceutical research firm. The private company is based in Tucson, AZ. The company was founded by Stephen Ralfe Evans-Freke. Selectide was acquired by Marion Merrell Dow, Inc. on January 27, 1995 for $58 million.

elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany.

Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda.

Celtic Pharma Development UK Plc provides financial management services. The company was founded in 2005 and is located in London, GB

Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA.

Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP.

Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments.

ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom.

Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL.

ADC Products Switzerland SARL develops antibody drug for the treatment of cancer. The company is headquartered in Epalinges, Switzerland.

A.T. Holdings II SARL is an investment holding Swiss company. The private company is based in Epalinges, Switzerland.

Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The private company is based in Reading, UK and was founded in 2014.

AAC-Air Ambulance Caribbean, Inc. provides air ambulance services. The private company is based in St. Thomas, U.S. Virgin Islands.

Castle Freke Farms Ltd. is a private company headquartered in Clonakilty, Ireland, that engages in mixed farming.